Type: News

The World Health Organization (WHO) announced in this week’s WHO Weekly Epidemiological Record that Malawi has been validated to have eliminated lymphatic filariasis as a public health problem.
On June 14, 2018, the US FDA approved moxidectin as a treatment for onchocerciasis (river blindness). We applaud Medicines Development for Global Health (MDGH)